Research into Muscle Disease in the University of Wales College of Medicine

 

The Institute of Medical Genetics has an international reputation for its research into genetic aspects of muscle disease.
  There are close links to the developing 
Wales Gene Park.
This includes work on the following disorders:   
Muscular Dystrophy   (Professor Peter Harper, Dr Mark Rogers)
The Cardiff team was responsible for finding the original myotonic dystrophy gene and a study is now in progress on defining the features of the recently recognised type 2 myotonic dystrophy (proximal myotonic myopathy, PROMM).

Both Dr Rogers and Professor Harper form part of the international ENMC consortium on type 2 myotonic dystrophy and the Myotonic Dystrophy Management and Therapy Consortium.

  Facioscapulohumeral Muscular Dystrophy

more information

 

Dr Mark Rogers (Clinical Consultant) and Dr Meena Upadhyaya (Principal Scientist) are closely involved in research on this disorder and are authors in a forthcoming book to be published shortly.

 
     
  Duchenne/Becker Muscular dystrophy    
 

The Cardiff research team played a major role in identifying the gene for this condition and is now responsible for genetic analysis as part of the Wales Genetics laboratory service.  An important ongoing project is the all Wales newborn screening programme for Duchenne dystrophy (led by Professor Angus Clarke), offered to all families living in Wales, which has closely analysed the social and family effects of detecting this disorder before symptoms have arisen.

 
 

A number of clinical studies on Duchenne dystrophy are also in progress, coordinated by Dr Jane Fenton May, based on the Wales register for the disorder.

 
     
  Genetics and Society  
 

Professor Angus Clark works closely with the departments with in the University of Wales has set up a forum to discuss and research these issues.

 
 


Comparative study of early and late onset of Parkinson's Disease
Researchers from the Universities of Cardiff and Bristol are conducting a study looking into Parkinson's disease (PD).
The aims of this study are to investigate the differences between Young Onset (beginning at an earlier ages than usual) and Late Onset PD.  This will give  vital clues as to why some people develop the condition and others do not.
Areas of particular interest include clinical features of PD, response to treatment and any complications related to treatment, family history of Parkinson's disease; and how Parkinson's disease affects quality of life.

Who would be eligible to participate?
ALL patients with Parkinson's disease who live in CARDIFF

Please click for further details

Or
contact                       

 

 
 


Genetics